Wegmans Pharmacy
Pharmaceutical ManufacturingNew York, United States201-500 Employees
Wegmans Pharmacy is a pharmaceuticals company based out of 675 Alberta Dr, Buffalo, New York, United States.
Market Growth Wegmans Pharmacy operates within the expanding pharmaceutical manufacturing industry with a revenue ranging from 500 million to 1 billion dollars, indicating significant market presence and potential for scalable partnerships.
Expansion Strategies Recent facility expansions in Ithaca and Harrison highlight Wegmans' commitment to increasing its physical footprint, presenting opportunities for supply chain enhancements, logistics solutions, or facility management services.
Recognition & Visibility Multiple awards for cross-platform marketing and outdoor advertising demonstrate Wegmans' active engagement in brand promotion, offering opportunities for advertising, digital marketing, or event sponsorship collaborations.
Product Safety Focus Recent product recall due to potential contamination indicates a focus on food safety and quality control, suggesting potential partnerships in quality assurance, safety testing, or supply chain management.
Technology Adoption Utilization of advanced tech stacks such as AutoCAD, Red Hat, and Autodesk BIM 360 shows a forward-looking approach, opening avenues for technology solutions, automation, or IT consulting services to support their operational needs.
Wegmans Pharmacy uses 8 technology products and services including AutoCAD, Netezza, Autodesk BIM 360, and more. Explore Wegmans Pharmacy's tech stack below.
| Wegmans Pharmacy Email Formats | Percentage |
| First.Last@wegmans.com | 95% |
| FirstLast@wegmans.com | 2% |
| First.L@wegmans.com | 2% |
| Last@wegmans.com | 1% |
Pharmaceutical ManufacturingNew York, United States201-500 Employees
Wegmans Pharmacy is a pharmaceuticals company based out of 675 Alberta Dr, Buffalo, New York, United States.
Wegmans Pharmacy's revenue is estimated to be in the range of $500M$1B
Wegmans Pharmacy's revenue is estimated to be in the range of $500M$1B